Status:
RECRUITING
CLOUD-R HAE REGISTRY
Lead Sponsor:
University Hospital, Grenoble
Conditions:
ANGIOEDEMA
Eligibility:
All Genders
Brief Summary
Angioedema is a disease characterized by the appearance of self-limiting edema that last 1-5 days and affect the subcutaneous tissue and/or gastrointestinal and oropharyngeal mucosa. In this last loca...
Detailed Description
The Grenoble center is the registry coordinator at the national level. It will contract directly with the Cloud R Company and will be in charge of coordinating the associated centers. It will therefor...
Eligibility Criteria
Inclusion
- Any patient with isolated angioedema without associated wheals.
- Patients with hereditary angioedema with or without C1 deficiency.
- Major patient with consent (signature)
- Minor patient whose parents / legal guardians have given their consent (signature)
Exclusion
- Patient unable to give consent.
- Wheals with angioedema
Key Trial Info
Start Date :
September 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2028
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT03845946
Start Date
September 1 2018
End Date
September 1 2028
Last Update
November 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Grenoble
Grenoble, Isere, France, 38043